A Liquid Biopsy Test for the Early Detection of High-Risk Colorectal Adenomas ASPIRE Award (2020-Present) Dan Landau, MD, PhD, Weill Cornell School of Medicine (Principal) and Claus Andersen, PhD, Aarhus University Read More
A Model System for Robust Identification of Neoantigen-Specific T-cell Receptors ASPIRE AWARD (2018-2020; 2020-PRESENT) Michelle Krogsgaard, PhD (Principal); Jef Boeke, PhD; and Jeffrey Weber, MD, PhD, New York University Read More
Tumor-Specific Immunotherapy for a Rare Pediatric Liver Cancer ASPIRE Award (2020-Present) Paul Thomas, PhD, St. Jude Children’s Research Hospital Read More
Exploiting Lymphatic Transport for Early Detection 2020 Emerging Leader Award Amanda Lund, PhD, New York University Read More
Elucidating the Mechanism of Menin-MLL Interaction Inhibition in NPM1c Mutated Acute Myeloid Leukemia Momentum Fellow (2020-Present) Hannah Uckelmann, PhD, Dana-Farber Cancer Institute Read More
Loss of the Non-Canonical BAF Complex as a Driver and Therapeutic Target in SF3B1-Mutant MDS and Leukemia IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT) Robert Bradley, PhD, Fred Hutchinson Cancer Research Center Read More
Targeting Leukemia Stem Cells by Disrupting Translational Fidelity IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT) Robert Signer, PhD, University of California San Diego Read More
Clonal Evolution of Pre-Leukemic Hematopoietic Stem Cells in Human Myeloid Malignancies IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT) Ravi Majeti, MD, PhD, Stanford University School of Medicine Read More
Development and Application of a Pan-Cancer Diagnostic Test for Early Detection of Cancer Momentum Fellow (2020-Present) Dimitrios Mathios MD, Johns Hopkins University School of Medicine Read More
Mechanisms of Tumor-Initiation in B-Lymphoid Malignancies IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT) Markus Müschen, MD, PhD, City of Hope Read More
Characterizing a Novel RasGRP1-mTOR Pathway in Immune and Cancer Cells Momentum Fellow (2020-Present) Kriti Bahl, PhD, University of California, San Francisco Read More
In Vivo Generation of Chimeric Antigen Receptor Cells to Treat Hemopoietic Malignancies IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT) Ron Levy, MD, Stanford University School of Medicine Read More
Dissecting Tumor Intrinsic and Immune Drivers of Resistance to Therapy in Non-Small Cell Lung Cancer Damon Runyon - Mark Foundation Physician-Scientist (2020-Present) Natalie Vokes, MD, Dana-Farber Cancer Institute Read More
Statistical Approaches for Earlier Detection of Cancer Momentum Fellow (2020-Present) Stephen Cristiano, PhD, Johns Hopkins University School of Medicine Read More
